Imaging biomarkers for the treatment of esophageal cancer
- PMID: 31293338
- PMCID: PMC6603816
- DOI: 10.3748/wjg.v25.i24.3021
Imaging biomarkers for the treatment of esophageal cancer
Abstract
Esophageal cancer is known as one of the malignant cancers with poor prognosis. To improve the outcome, combined multimodality treatment is attempted. On the other hand, advances in genomics and other "omic" technologies are paving way to the patient-oriented treatment called "personalized" or "precision" medicine. Recent advancements of imaging techniques such as functional imaging make it possible to use imaging features as biomarker for diagnosis, treatment response, and prognosis in cancer treatment. In this review, we will discuss how we can use imaging derived tumor features as biomarker for the treatment of esophageal cancer.
Keywords: Computed tomography perfusion; Diffusion-weighted imaging; Dynamic-contrast-enhanced magnetic resonance imaging; Esophageal cancer; Positron emission tomography; Texture analysis.
Conflict of interest statement
Conflict-of-interest statement: We confirm that there are no known conflicts of interest associated with this publication, and there has been no significant financial support for this work that may have influence on the contents.
Figures




Similar articles
-
Optimization of b-values in diffusion-weighted imaging for esophageal cancer: Measuring the longitudinal length of gross tumor volume and evaluating chemoradiotherapeutic efficacy.J Cancer Res Ther. 2017;13(5):748-755. doi: 10.4103/jcrt.JCRT_630_17. J Cancer Res Ther. 2017. PMID: 29237898
-
Treatment results of neoadjuvant chemoradiotherapy followed by radical esophagectomy in patients with initially inoperable thoracic esophageal cancer.Jpn J Radiol. 2018 Jan;36(1):23-29. doi: 10.1007/s11604-017-0693-0. Epub 2017 Oct 28. Jpn J Radiol. 2018. PMID: 29080946
-
Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.Gastroenterology. 2018 Jan;154(2):437-451. doi: 10.1053/j.gastro.2017.09.048. Epub 2017 Oct 14. Gastroenterology. 2018. PMID: 29037469
-
PET/Computed Tomography Scanning and Precision Medicine: Esophageal Cancer.PET Clin. 2017 Oct;12(4):373-391. doi: 10.1016/j.cpet.2017.05.001. Epub 2017 Jul 28. PET Clin. 2017. PMID: 28867110 Review.
-
Stage-directed individualized therapy in esophageal cancer.Ann N Y Acad Sci. 2016 Oct;1381(1):50-65. doi: 10.1111/nyas.13113. Epub 2016 Jul 6. Ann N Y Acad Sci. 2016. PMID: 27384385 Review.
Cited by
-
Spectral CT-based nomogram for evaluation of neoadjuvant chemotherapy response in esophageal squamous cell carcinoma.Eur Radiol. 2025 Jul;35(7):3800-3811. doi: 10.1007/s00330-024-11294-2. Epub 2024 Dec 27. Eur Radiol. 2025. PMID: 39729110
-
An artificial neural network-based radiomics model for predicting the radiotherapy response of advanced esophageal squamous cell carcinoma patients: a multicenter study.Sci Rep. 2023 May 29;13(1):8673. doi: 10.1038/s41598-023-35556-z. Sci Rep. 2023. PMID: 37248363 Free PMC article.
-
Potential use of high-resolution T2-weighted MRI with histopathologic findings in staging esophageal cancer.Quant Imaging Med Surg. 2023 Jan 1;13(1):249-258. doi: 10.21037/qims-22-376. Epub 2022 Oct 22. Quant Imaging Med Surg. 2023. PMID: 36620170 Free PMC article.
-
HOXA10 enhances cell proliferation and suppresses apoptosis in esophageal cancer via activating p38/ERK signaling pathway.Open Med (Wars). 2022 Nov 3;17(1):1750-1759. doi: 10.1515/med-2022-0558. eCollection 2022. Open Med (Wars). 2022. PMID: 36407869 Free PMC article.
-
Survival outcome prediction of esophageal squamous cell carcinoma patients based on radiomics and mutation signature.Cancer Imaging. 2025 Jan 31;25(1):9. doi: 10.1186/s40644-024-00821-5. Cancer Imaging. 2025. PMID: 39891186 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
-
- Chen G, Wang Z, Liu XY, Liu FY. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg. 2007;31:1107–1114. - PubMed
-
- Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205–211. - PubMed
-
- Axel L. Cerebral blood flow determination by rapid-sequence computed tomography: Theoretical analysis. Radiology. 1980;137:679–686. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical